eGenesis
Highly Engaged Employees
Highly Engaged EmployeesBusiness Services · Massachusetts, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
101 Cambridgepark Dr Ste 200, Cambridge,...Phone Number
(617) 941-7500Website
www.egenesisbio.comRevenue
$20.5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
3
1
1
About eGenesis
Founded in 2015, eGenesis is a gene editing and genome engineering company committed to the development of human transplantable organs, tissues, and cells. They are headquartered in Cambridge, Massachusetts.Explore more
eGenesis Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is eGenesis your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
eGenesis, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if eGenesis is spiking on competitors!
Earning: See what the market has to say on eGenesis recently announced quarterly report
Check if eGenesis has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at eGenesis
Click to see if eGenesis had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once eGenesis has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when eGenesis launches new products
Recommended Actions
Reach out to Masked Content who joined eGenesis as Masked Content
Find 2 more new buyers
Compare Similar Companies to eGenesis
Compare insights from companies similar to eGenesis, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
eGenesis is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
eGenesis is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about eGenesis.
eGenesis financials insights
Gather financial insights about eGenesis, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2016
Angel/Seed
$2M
2017
Series A
$38M
2019
Series B
$100M
2021
Series C
$125M
2024
Series D
$191M
eGenesis Tech Stack
A closer look at the technologies used by eGenesis
Most Recent Scoops
Hiring Plans
eGenesis has more open roles in Medical & Health than it has had at any time in the past 12 months.
Hiring Plans
Event
Product Marketing, Events, Learning & Development, Software, Bioengineering, Pharmaceuticals, Public Health, Field /Outside Sales, Field Marketing, Healthcare Technology, Patient Experience
Event
Product Marketing, Events, Learning & Development, Software, Bioengineering, Pharmaceuticals, Public Health, Field /Outside Sales, Field Marketing, Healthcare Technology, Patient Experience
New Hire
Executive Move
Executive Moves, New Hire
Funding
Funding
eGenesis News & Media
eGenesis and OrganOx Announce U.S. FDA Clearance of IND Application for the Treatment of Patients with Acute-On-Chronic Liver Failure
CAMBRIDGE, Mass. & OXFORD, England--(BUSINESS WIRE)-- #engineering--eGenesis and OrganOx Announce U.S. FDA Clearance of IND Application for the Treatment of Patients with Acute-On-Chronic Liver FailureeGenesis Announces Second Patient Successfully Transplanted with Genetically Engineered Porcine Kidney
CAMBRIDGE, Mass.--(BUSINESS WIRE)-- #engineering--eGenesis announces second patient successfully transplanted with genetically engineered porcine kidney.OrganOx and eGenesis Announce Exclusive Clinical Co-Development Agreement for Treatment of Patients with Liver Failure in the Acute Setting
OrganOx and eGenesis Announce Exclusive Clinical Co-Development Agreement for Treatment of Patients with Liver Failure in the Acute SettingeGenesis Bags $191 Million Series D
CAMBRIDGE, MA, eGenesis, a biotechnology company developing human-compatible engineered organs to address the global organ shortage, today announced the close of a $191 million Series D financing.
Read more news
Top Business Services Companies
See more top companies
Frequently Asked Questions Regarding eGenesis
Sign Up For FreeTo access detailed company insights
Founded in 2015, eGenesis is a gene editing and genome engineering company committed to the development of human transplantable organs, tissues, and cells. They are headquartered in Cambridge, Massachusetts.... Read More
